CBio Limited notice to prospective investors
Important notice
The information on this page is not part of the Prospectus. You must read this important notice before you attempt to access the electronic version of the Prospectus on this website, and indicate your agreement or otherwise at the bottom of this notice. If you agree to these conditions, you will be given access to the electronic Prospectus.
Date and Duration of the Offer
CBio Limited ACN 094 730 417 (CBIO) lodged a Prospectus for the issue of up to 30,000,000 shares in CBio with the Australian Securities & Investments Commission on 10 November 2009. The Prospectus details the terms of the offer. The offer is expected to close at 5.00pm on 29 January 2010. CBio reserves the right to change this date without notice.
Exposure Period
Application for CBio’s shares under the Prospectus will not be accepted by CBio during the period of seven days after the date of the Prospectus, or such other period (not exceeding fourteen days), as ASIC may require (Exposure Period). Applications may only be made on the Application Form attached to or accompanying the Prospectus (including the electronic copy of the Prospectus). Applications will not be processed until after the expiry of the Exposure Period. No preference will be conferred on Applications received during the Exposure Period.
Jurisdiction
Access to the Prospectus is only available to residents of the Commonwealth of Australia, from within Australia. The distribution of this Prospectus in jurisdictions outside of Australia may be restricted by law and persons in such jurisdictions who come into possession of the Prospectus should seek advice on and observe any such restrictions. Any failure to comply with such restrictions may constitute a violation of applicable securities laws. The Prospectus does not constitute an offer or an invitation in any jurisdiction in which, or to any person to whom, it would not be lawful to make such an offer or invitation. The Offer is being made only to persons receiving this Prospectus in Australia. No action has been taken to register the Prospectus or otherwise permit a public offering of CBio’s Shares in any jurisdiction outside Australia. The Prospectus provided on the CBio website is available to persons accessing this website from within Australia only. If you are accessing this site from anywhere outside Australia, do not download, print or view the Prospectus accessible through this web page. By accessing the Prospectus, you acknowledge and confirm that you are accessing this website from within Australia. The Prospectus does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or to any US person (as defined in Regulation S under the US Securities Act of 1933, as amended (US Securities Act), and is not available to persons in the United States or to US persons. The securities in the offering have not been and will not be registered under the US Securities Act or the securities laws of any state of the United States and may not be offered or sold in the United States or to US persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and applicable state securities laws.
Acceptance Forms
Following the Exposure Period CBio will accept paper copies of the application form made using a print-out of the electronic application form or from the paper copy of the Prospectus. CBio will not accept an application form submitted electronically. To obtain a paper copy of the Prospectus free of charge during the Offer Period, please contact CBio on 07 3841 4844. CBio will not accept a completed application form if it is has reason to believe that: the applicant has not received a complete paper copy or the electronic copy of the Prospectus; or the application form or electronic copy of the Prospectus has been altered or tampered with in any way. The full Prospectus has 92 pages. The electronic copy of the full Prospectus is in Adobe Portable Document format (PDF). The size of the full Prospectus is approximately 2000kb. You should ensure that any copy you view or print is complete.
Investors must seek advice
Nothing contained on this website or in the Prospectus constitutes investment, legal, business, tax or other advice. In particular, the information on this website and in the Prospectus is not tailored to your investment objectives, financial situation or particular needs. In making an investment decision, you must rely on your own examination of CBio, the securities and the terms of the offering, including the merits and risks involved. You should consult your professional adviser for legal, business or tax advice.
Supplementary Prospectus
A Supplementary Prospectus dated 7 December 2009 has been lodged with ASIC and forms part of this IPO Prospectus. The Supplementary Prospectus is available here and must be read in conjunction with the IPO Prospectus.
Acceptance of Conditions
By proceeding, I agree to the above statements, and confirm that I am a resident of Australia accessing this website from Australia. In addition, I represent, warrant and agree that I am not a resident of the United States or currently located in the United States, nor am I acting for the account or benefit of any person in the United States, a US person or any other foreign person, and that I will not make a copy of the Prospectus available to, or distribute a copy of the Prospectus to, any such non-Australian resident person. I agree that I will read the IPO Prospectus dated 10 November 2009 in conjunction with the Supplementary Prospectus dated 7 December 2009.
I CANNOT AGREE.
I AGREE.
